Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About Molecular Pharmacology
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • For Subscribers
    • For Advertisers
    • Terms & Conditions of Use
    • Permissions
  • About Us
    • About Molecular Pharmacology
    • Feedback
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

July 01, 1987; Volume 32,Issue 1
  • You have access
    Structural characteristics of the 35- and 36-kDa forms of the beta subunit common to GTP-binding regulatory proteins.
    M J Woolkalis and D R Manning
    Molecular Pharmacology July 1987, 32 (1) 1-6;
  • You have access
    Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives.
    M Hagiwara, M Inagaki, M Watanabe, M Ito, K Onoda, T Tanaka and H Hidaka
    Molecular Pharmacology July 1987, 32 (1) 7-12;
  • You have access
    Effects of cis- and trans-tamoxifen isomers on RNA incorporation of human breast cancer cells.
    C Benz and G F Santos
    Molecular Pharmacology July 1987, 32 (1) 13-16;
  • You have access
    Characterization of a subline of P388 leukemia resistant to amsacrine: evidence of altered topoisomerase II function.
    S R Per, M R Mattern, C K Mirabelli, F H Drake, R K Johnson and S T Crooke
    Molecular Pharmacology July 1987, 32 (1) 17-25;
  • You have access
    Interactions between adenosine and alpha 1-adrenergic agonists in regulation of respiration in hamster brown adipocytes.
    R J Schimmel, M E Elliott and V C Dehmel
    Molecular Pharmacology July 1987, 32 (1) 26-33;
  • You have access
    Solubilization and reconstitution of vasopressin V1 receptors of rat liver.
    N Aiyar, P Nambi, F Stassen and S T Crooke
    Molecular Pharmacology July 1987, 32 (1) 34-36;
  • You have access
    Phorbol ester-stimulated bidirectional transmembrane calcium flux in A7r5 vascular smooth muscle cells.
    G Sperti and W S Colucci
    Molecular Pharmacology July 1987, 32 (1) 37-42;
  • You have access
    The relationship between alpha 1-adrenergic receptor occupancy and response in BC3H-1 muscle cells.
    R D Brown, K D Berger and P Taylor
    Molecular Pharmacology July 1987, 32 (1) 43-52;
  • You have access
    Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors.
    M J Howard, R J Hughes, H J Motulsky, M D Mullen and P A Insel
    Molecular Pharmacology July 1987, 32 (1) 53-58;
  • You have access
    Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
    K M MacLeod, D D Ng, K H Harris and J Diamond
    Molecular Pharmacology July 1987, 32 (1) 59-64;
  • You have access
    Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
    A Convents, J P De Backer, D Convents and G Vauquelin
    Molecular Pharmacology July 1987, 32 (1) 65-72;
  • You have access
    Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
    S K Yang and Z P Bao
    Molecular Pharmacology July 1987, 32 (1) 73-80;
  • You have access
    Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas.
    S K Fisher and R M Snider
    Molecular Pharmacology July 1987, 32 (1) 81-90;
  • You have access
    Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
    M Waelbroeck, M Gillard, P Robberecht and J Christophe
    Molecular Pharmacology July 1987, 32 (1) 91-99;
  • You have access
    Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    M Gillard, M Waelbroeck and J Christophe
    Molecular Pharmacology July 1987, 32 (1) 100-108;
  • You have access
    Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    S M Kazmi and R K Mishra
    Molecular Pharmacology July 1987, 32 (1) 109-118;
  • You have access
    Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
    B A Dodson, L M Braswell and K W Miller
    Molecular Pharmacology July 1987, 32 (1) 119-126;
  • You have access
    Calmodulin may play a pivotal role in neurotransmitter-mediated inhibition and stimulation of rat cerebellar adenylate cyclase.
    M K Ahlijanian and D M Cooper
    Molecular Pharmacology July 1987, 32 (1) 127-132;
  • You have access
    Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
    A Laurenza, Y Khandelwal, N J De Souza, R H Rupp, H Metzger and K B Seamon
    Molecular Pharmacology July 1987, 32 (1) 133-139;
  • You have access
    Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839.
    T Nakajima and A Katoh
    Molecular Pharmacology July 1987, 32 (1) 140-146;
  • You have access
    Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
    R T Coughlin, T Akera, E J McGroarty and C Steinbach
    Molecular Pharmacology July 1987, 32 (1) 147-153;
  • You have access
    Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
    U Lönn and S Lönn
    Molecular Pharmacology July 1987, 32 (1) 154-161;
  • You have access
    The anti-HTLV-III (anti-HIV) and cytotoxic activity of 2',3'-didehydro-2',3'-dideoxyribonucleosides: a comparison with their parental 2',3'-dideoxyribonucleosides.
    J Balzarini, G J Kang, M Dalal, P Herdewijn, E De Clercq, S Broder and D G Johns
    Molecular Pharmacology July 1987, 32 (1) 162-167;
  • You have access
    alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
    J A Blank, A N Tucker, J Sweatlock, T A Gasiewicz and M I Luster
    Molecular Pharmacology July 1987, 32 (1) 169-172;
  • You have access
    Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenz(a,h)anthracene.
    W Lilienblum, K L Platt, G Schirmer, F Oesch and K W Bock
    Molecular Pharmacology July 1987, 32 (1) 173-177;
  • You have access
    Beta-adrenergic receptor subtype is an intrinsic property of the receptor gene product.
    C D Strader, M R Candelore, E Rands and R A Dixon
    Molecular Pharmacology August 1987, 32 (1) 179-183;
  • You have access
    A new high affinity, iodinated adenosine receptor antagonist as a radioligand/photoaffinity crosslinking probe.
    G L Stiles and K A Jacobson
    Molecular Pharmacology August 1987, 32 (1) 184-188;
  • You have access
    Immunohistochemical localization and quantitation of NADPH-cytochrome P-450 reductase in human liver.
    M E McManus, P D Hall, I Stupans, J Brennan, W Burgess, R Robson and D J Birkett
    Molecular Pharmacology August 1987, 32 (1) 189-194;
  • You have access
    Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be related.
    R G Shorr, M D Minnich, A Varrichio, M W Strohsacker, L Gotlib, L I Kruse, W E DeWolf and S T Crooke
    Molecular Pharmacology August 1987, 32 (1) 195-200;
  • You have access
    Relative abundance of two molecular forms of Na+,K+-ATPase in the ferret heart: developmental changes and associated alterations of digitalis sensitivity.
    Y C Ng and T Akera
    Molecular Pharmacology August 1987, 32 (1) 201-205;
  • You have access
    Co-induction of cytochrome P-450 isozymes in rat liver by 2,4,5,2',4',5'-hexachlorobiphenyl or 3-methoxy-4-aminoazobenzene.
    M Kelley, P Hantelle, S Safe, W Levin and P E Thomas
    Molecular Pharmacology August 1987, 32 (1) 206-211;
  • You have access
    Calmodulin stimulation of the rat cerebral cortical adenylate cyclase is required for the detection of guanine nucleotide- or hormone-mediated inhibition.
    E Perez-Reyes and D M Cooper
    Molecular Pharmacology August 1987, 32 (1) 212-216;
  • You have access
    Effect of ethanol on mouse cerebral cortical beta-adrenergic receptors.
    P Valverius, P L Hoffman and B Tabakoff
    Molecular Pharmacology August 1987, 32 (1) 217-222;
  • You have access
    SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4.
    S Mong, H L Wu, J Miller, R F Hall, J G Gleason and S T Crooke
    Molecular Pharmacology August 1987, 32 (1) 223-229;
  • You have access
    Muscarinic cholinergic receptors in the embryonic chick heart: interaction of agonist, receptor, and guanine nucleotides studied by an improved assay for direct binding of the muscarinic agonist [3H]cismethyldioxolane.
    J B Galper, L S Haigh, A C Hart, D S O'Hara and D J Livingston
    Molecular Pharmacology August 1987, 32 (1) 230-240;
  • You have access
    Alpha 2-adrenoceptor stimulation affects total glucose utilization in isolated islets of Langerhans.
    S G Laychock
    Molecular Pharmacology August 1987, 32 (1) 241-248;
  • You have access
    Heterologous regulations of cAMP responses in pregnant rat myometrium. Evolution from a stimulatory to an inhibitory prostaglandin E2 and prostacyclin effect.
    Z Tanfin and S Harbon
    Molecular Pharmacology August 1987, 32 (1) 249-257;
  • You have access
    Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
    R M McKernan, M J Howard, H J Motulsky and P A Insel
    Molecular Pharmacology August 1987, 32 (1) 258-265;
  • You have access
    gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
    J S Yang and R W Olsen
    Molecular Pharmacology August 1987, 32 (1) 266-277;
  • You have access
    Voltage-dependent nitrendipine binding to cardiac sarcolemmal vesicles.
    T J Kamp and R J Miller
    Molecular Pharmacology August 1987, 32 (1) 278-285;
  • You have access
    Potent activity of 5-fluoro-2'-deoxyuridine and related compounds against thymidine kinase-deficient (TK-) herpes simplex virus: targeted at thymidylate synthase.
    E De Clercq, J Bères and W G Bentrude
    Molecular Pharmacology August 1987, 32 (1) 286-292;
  • You have access
    Mechanism of transport for toxic cysteine conjugates in rat kidney cortex membrane vesicles.
    V H Schaeffer and J L Stevens
    Molecular Pharmacology August 1987, 32 (1) 293-298;
  • You have access
    Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
    L M Bornheim, M C Underwood, P Caldera, A E Rettie, W F Trager, S A Wrighton and M A Correia
    Molecular Pharmacology August 1987, 32 (1) 299-308;
  • You have access
    The role of formate and S-adenosylmethionine in the reversal of nitrous oxide inhibition of formate oxidation in the rat.
    A B Makar and T R Tephly
    Molecular Pharmacology August 1987, 32 (1) 309-314;
  • You have access
    Effect of beta-naphthoflavone on mitochondrial supply of reducing equivalents for monooxygenation in periportal and pericentral regions of the liver lobule.
    S A Belinsky, F W Kari, F C Kauffman and R G Thurman
    Molecular Pharmacology August 1987, 32 (1) 315-320;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 32, Issue 1
1 Jul 1987
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Hypoxia-Inducible Factor-1 (HIF-1)
  • Cannabinoid Receptor-Mediated Apoptosis Induced by R(+)-Methanandamide and Win55,212-2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Pharmacology of Vanilloid Transient Receptor Potential Cation Channels
  • Contribution of the Major Copper Influx Transporter CTR1 to the Cellular Accumulation of Cisplatin, Carboplatin, and Oxaliplatin
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2018 by the American Society for Pharmacology and Experimental Therapeutics